Semiconductor Manufacturing International (shanghai) Corporation

Semiconductor Manufacturing International (beijing) Corporation

Other

Chen Yi Huang

Chia Chi Yang

Tao Jiang

Cheng Yi Huang

Truc Ngoc Nguyen

Pierre-Yves Michellys

Baogen Wu

Thomas H Marsilje, Iii

Bei Chen

Xuefeng Zhu

Wei Pei

Zhi Bing Deng

Jun Tao Guo

Wen Jun Weng

Yonghui Ge

Zhaobo Gao

Yuncheng Li

Level-shifter circuits and methods of using the same are provided. A level-shifter circuit includes a latch unit and a level-shifting unit. The latch unit is configured to generate a latch signal for storing a logic state of a first digital signal in a first power supply domain. The level-shifting unit is configured to shift a voltage of the latch signal to output a second digital signal in a second power supply domain. The latch unit and the level-shifting unit are powered by a power supply voltage in the second power supply domain.

Level-shifter circuits and methods of using the same

A power supply circuit, its generating and control methods are presented, relating to smart wearable devices. The power supply circuit comprises a Bandgap voltage reference, a real-time detection and control circuit, and a substitute voltage source. The real-time detection and control circuit is connected to the Bandgap voltage reference and the substitute voltage source, and adjusts an output voltage of the substitute voltage source to match an output voltage of the Bandgap voltage reference. After these output voltages are equal, the output voltage of the power supply circuit is provided by the substitute voltage source, and the Bandgap voltage reference can be disconnected from the circuit. This circuit can lower the power consumption of the Bandgap voltage reference without affecting the stability of the voltage output.

Power supply circuit and a method of controlling the same

The invention provides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, c-ros oncogene (ROS), insulin-like growth factor (IGF-1R), and/or insulin receptor (InsR) or a combination thereof. 

Compounds and compositions as protein kinase inhibitors

Growing community of inventors

Shanghai, China

Chen Yi Huang